Avalo Therapeutics Inc. buy HC Wainwright
Start price
02.06.25
/
50%
€0.041
Target price
02.06.26
€13.19
Performance (%)
-
End price
03.06.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avalo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% |
Comments by HC_Wainwright for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics, Inc. (NASDAQ: AVTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat
In the thread Trading Avalo Therapeutics Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Current prediction by HC_Wainwright for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
17.09.25
17.09.25
€21.09
17.09.26
17.09.26
-
28.12.23
28.12.23
Stopped prediction by HC_Wainwright for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
14.05.26
14.05.26
€29.88
14.05.27
14.05.27
-
28.12.23
28.12.23
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
25.03.26
25.03.26
€34.46
25.03.27
25.03.27
-
28.12.23
28.12.23
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.041
15.01.26
15.01.26
€21.48
15.01.27
15.01.27
-
28.12.23
28.12.23